The Chris Stigall Show 6:00am - 9:00am

Listen Live

Search

Defense Attorneys Monitor DOJ’s Shift in Charging Strategies

Wednesday, February 18, 2026 at 6:45 AM

Criminal defense attorneys are closely observing changes in how the Justice Department approaches prosecutions. They're documenting instances where the DOJ appears to use unconventional charging methods and potentially aggressive legal strategies.

Defense attorneys across the country are keeping close watch on what they describe as a shift in the Justice Department’s approach to criminal prosecutions.

Legal professionals are documenting cases where federal prosecutors appear to be employing unconventional charging strategies, including what some characterize as aggressive legal theories and potential politically-motivated prosecutions.

The attorneys are systematically monitoring instances where the DOJ’s charging decisions seem to deviate from traditional prosecutorial practices, raising questions about consistency in how federal cases are being handled.

This increased scrutiny comes as defense lawyers note patterns in federal charging decisions that they believe represent a departure from historical norms in criminal justice proceedings.

Share

More from TV Delmarva Channel 33 News

  • Palestinians Mark Ramadan Among Destroyed Mosques in Gaza

    The Muslim holy month of Ramadan began Wednesday in Gaza as Palestinians gathered to pray in the debris of destroyed mosques and temporary shelters. Many worshippers mourned the loss of their sacred spaces while attempting to observe the religious period amid widespread destruction.

  • New Jersey Data Analytics Firm Verisk Exceeds Q4 Profit Expectations

    Verisk, a New Jersey-based insurance data analytics company, reported fourth-quarter earnings that surpassed Wall Street predictions, driving shares up nearly 10% in pre-market trading. The strong performance came despite challenges from reduced weather activity and a smaller federal contract.

  • Medical Device Company Exceeds Expectations with Insulin Pump Sales Growth

    Insulet Corporation surpassed Wall Street projections for the fourth quarter, driven by increased sales of its tubeless insulin delivery devices. The company reported a 31% revenue jump and announced plans for significant stock buybacks in 2026.

  • Drug Research Company Projects Strong 2026 Profits as Biotech Demand Rebounds

    Charles River Laboratories announced Wednesday it expects 2026 profits to exceed Wall Street predictions, citing recovering demand from biotechnology companies for drug research services. The Massachusetts-based contract research firm reported fourth-quarter earnings that beat analyst expectations despite some revenue challenges.